- Springboard Pro is a specialist in design and development of medical devices.
- Springboard Pro will significantly enhance Sanner Group’s design and development capabilities; allowing Sanner to continue to drive growth in the MedTech and Diagnostic CDMO segments.
London, UK – Global Healthcare Opportunities, or GHO Capital Partners LLP (“GHO”), the European specialist investor in global healthcare, acknowledges the announcement from its portfolio company Sanner Group, regarding its acquisition of Springboard Pro (“Springboard”).
Sanner Group, a leading global healthcare packaging manufacturer and medical device CDMO has announced that it has acquired Springboard Pro (Springboard), a specialist in the design and development of medical devices for regulated markets, boosting Sanner Group’s in-house medical technology and diagnostics development capabilities and see the establishment of a new Design Center of Excellence in the UK.
Springboard is a specialist in developing devices from an initial concept through to manufacture with a full suite of engineering, multidisciplinary scientific skills and forensic engineering capabilities, delivering a full service offering to its customers for both pre- and post-product launch. Its UK-based team of experts in physics, electronics, software, and materials science holds a strong reputation for fast and cost-effective regulated device development. Springboard’s expertise spans across drug delivery devices, such as autoinjectors, infusion pumps, inhalers and syringes, and equipment and consumables in the fields of respiratory, surgical, critical care, implantables, diagnostics and biotechnology.
Hans-Willem van Vliet, CEO of Sanner Group, commented: “Sanner Group has transformed from a market leader in desiccant closures and effervescent tablet packaging, to a sought-after provider of customer-specific solutions in the fields of medical technology, diagnostics, pharmaceuticals and consumer healthcare. The acquisition of Springboard further strengthens this offering, giving our customers deep expertise and support across the entire medical device development process, from initial concept design to commercial manufacturing.
“Springboard’s strong reputation for delivering exceptional concept through to manufacture design services, along with its ability to solve complex technical and scientific problems for its customers combined with an excellent culture, make this a highly complementary acquisition. We very much look forward to welcoming the Springboard team to the Sanner Group and delivering excellence at all stages of the product lifecycle.”
“We are excited to join Sanner Group to form its Design Center of Excellence for medical device development,” said Tom Oakley, Director of Springboard. “Our clients, from the largest multinational companies to the fastest growing startups, will not only be able to access design innovation based on first class scientific and engineering capabilities, but also benefit from integrated design for manufacturing. We can support every project from small-scale production for verification and clinical trials to full-scale serial production within the Sanner Group’s global manufacturing facilities.”
Keith Turner, Director of Springboard, further added, “Our combination with Sanner Group brings world-class intelligent healthcare solutions to our clients, and is a major step in our growth journey. Sanner and Springboard have a shared commitment to improve people’s lives around the world and we are excited to be pursuing this objective together.”